Frailty Score-guided Dosing of Lenalidomide, Dexamethasone and Daratumumab Induction Therapy

Clinical trial NCT04223661 · WITHDRAWN

Trial details

NCT number: NCT04223661
Sponsor: Attaya Suvannasankha
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2021-12-06
Primary completion: 2022-12-31
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.